Fighting against the spread of Measles
Public safety alert issued for 'dangerous subject' at large
The current cases of Measles started from people who have come back to the country from international travels where measles is endemic.
'The virus is taking hold in communities where vaccination rates are low and that's the really tough thing, measles is incredibly contagious. Experts estimate that we need to have a 95% vaccination rate or better in order to prevent outbreaks from taking hold,' Monument Health Pediatrician Dr. Paula Marsland said.
These percentages have dropped to around 90% across the country.
Medical professionals are recommending the MMR vaccine (Measles-Mumps-Rubella Vaccination), something that has remained the same for the past 50 years.
'It's not hanging out in animals, it's hanging out in humans. And so as we try to eradicate it, the only way to do that is to stop the transmission of human to human. That's why I mentioned previously, it's highly contagious. Measles is three times more contagious than the Flu, than Covid, than Ebola,' Dr. Marsland said.
The last time this many cases happened in the country was back in 2019, when over 1,200 cases were reported for the entire year.
'And then once symptoms show up, folks are infectious from roughly four or five days before the rash starts to four days after the rash starts. So that's a good eight to nine-day period where they are infectious. So certainly if you had somebody with a positive measles case, we'd want them to quarantine until at least four days after the rash started,' Dr. Marsland said.
Currently, there have been over 1,100 cases this year, with over two-thirds being in people ages 19 and younger.
The measles vaccine is typically given between 12-15 months of age with the second dose of MMR given in the range of 4-6 years of age.
If you want to learn more about next steps in preventing measles, talk to your medical professional or find more informaiton here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Politico
an hour ago
- Politico
Will feds weigh in on religious vax carveouts?
Driving the Day RELIGIOUS VAX EXEMPTIONS — It's back-to-school season, which means parents are shuttling their kids to pediatricians for annual checkups — and advocates for and against states' exemptions to vaccine mandates for school entry are gearing up for a fight, Lauren reports. Vaccine skeptics have sought to make their case to the Trump administration's Religious Liberty Commission — created by executive order in May — for executive action to bolster religious carve-outs. But they face pushback from public health experts who warn that more exemptions could threaten public health, setting up another front in the vaccine wars. Four states — California, Connecticut, Maine and New York — don't offer religious exemptions to school vaccine requirements, and Massachusetts lawmakers are considering banning them. West Virginia provides exemptions after GOP Gov. Patrick Morrisey signed an executive order earlier this year invoking the state's religious freedom law. Some religious liberty groups have called on the federal government — which has no say in state vaccine mandates — to use federal education funding as leverage to expand religious opt-outs from school immunization requirements, pointing to a Clinton-era religious protection statute. Precedential web: Some vaccine law experts question how far the executive branch could go to nudge those outlier states toward accepting religious exemptions. The Supreme Court curtailed the Religious Freedom Restoration Act's application to the states in 1997, and administrative conditions on federal funding can't run afoul of Congress' directions. But proponents say those lawyers ignore more recent opinions that work in exemption advocates' favor, pointing to a Covid-19-era decision lifting in-home gathering restrictions on religious grounds and, more recently, the court's ruling in favor of parents who want to opt their children out of LGBTQ+-themed lessons in public schools. Shifting winds: The number of kindergarteners entering school with at least one vaccine exemption continues to tick up, with the CDC reporting last week that 3.6 percent had one in the 2024-2025 school year, compared with 2.2 percent a decade ago. Days before the updated data was released, the American Academy of Pediatrics reaffirmed its opposition to religious exemptions, arguing they should be abolished to protect public health. 'In practice, nonmedical exceptions based on religious belief can substantially limit the public health value of vaccine requirements for school attendance,' the group said in a statement. 'There is no practicable way for schools or other involved community partners to distinguish fairly among religious or other nonmedical claims.' What's next: The Religious Liberty Commission will hold a hearing next month on public education issues, giving exemption proponents another opening to make their case. It's unclear where the White House stands on the concept — a spokesperson didn't comment — but the first Trump administration's HHS pursued avenues to grant health care workers expanded 'conscience' protections and to allow imports of certain vaccines due to some patients' religious beliefs. IT'S TUESDAY. WELCOME BACK TO PRESCRIPTION PULSE. Your host is wondering whether concerns about a common allergy medicine's risks might catch the FDA's attention. Send tips to David Lim (dlim@ @davidalim or davidalim.49 on Signal) and Lauren Gardner (lgardner@ @Gardner_LM or gardnerlm.01 on Signal). Eye on the FDA NEW TOP LAWYER — FDA Commissioner Marty Makary named a longtime government attorney on Monday to be the agency's chief counsel, months after his first pick was torpedoed by Sen. Josh Hawley (R-Mo.). Sean Keveney, who most recently served as HHS's acting general counsel, served as a career civil servant at DOJ's civil rights division before becoming deputy general counsel at HHS in 2019, according to the department and his LinkedIn profile. His predecessor in the position, Hilary Perkins, was also a career DOJ lawyer whose appointment drew Hawley's ire before Makary's confirmation because of her record defending the Biden administration's abortion pill policies. While Perkins also defended the Trump FDA's mifepristone positions, that wasn't enough to overcome his opposition, and she ultimately stepped down days into the job. MDUFA KICKOFF — The FDA's medical device user fee program is not set to expire until Sept. 30, 2027, but the process to renew it has already begun. Despite HHS Secretary Robert F. Kennedy Jr.'s vocal distaste for the user fee programs, the Trump administration has made it clear they are committed to the monthslong process that will likely result in their renewal for another five years. Industry and FDA leaders — including FDA Commissioner Marty Makary and Center for Devices and Radiological Health Director Michelle Tarver — met Monday to discuss the potential sixth iteration of the medical device user fee program. 'While user fees support timeliness and predictability by providing FDA with additional resources, user fees are not a guarantee of approval,' AdvaMed's senior executive vice president, Janet Trunzo, said according to prepared remarks. 'They never have been, and they never should be.' In Congress SENATE PASSES FDA FUNDING — Before leaving town for the August recess, the Senate passed a bill to fund the FDA for fiscal 2026 as part of a minibus package by an 87-9 vote. The legislation, which funds the agency at $7 billion, is made up of $3.6 billion in taxpayer funds and $3.4 billion in user fee revenues. But it is unclear whether lawmakers will have to turn to a continuing resolution before government funding runs out at the end of September. The House Appropriations Committee previously advanced an FDA bill that funded the agency at a lower level. Research Corner BOOST FOR WOMEN'S HEALTH — The Gates Foundation said Monday it would spend $2.5 billion through 2030 to speed global women's research into maternal, menstrual, gynecological and sexual health. Pharma Moves Erika Sward is now chief advocacy officer at UsAgainstAlzheimer's. She previously was assistant vice president of national advocacy at the American Lung Association. Document Drawer FDA Commissioner Marty Makary met with Rep. John Joyce (R-Pa.) for an introductory meeting on July 24. He also met with People for the Ethical Treatment of Animals to discuss nonanimal testing approaches on July 21, according to newly posted public calendar disclosures. He also met with the leadership team of the Government Accountability Office on July 16 to discuss 'items of mutual interest.' WHAT WE'RE READING Top FDA cancer medicine regulator Richard Pazdur played a critical role in the rejection of Replimune Group's skin cancer therapy, STAT's Adam Feuerstein reports. Longevity companies are eyeing Montana as a potential hub for 'biohacking' treatments thanks to state laws embracing patients' 'right-to-try' experimental drugs, The Wall Street Journal's Alex Janin writes.
Newsweek
an hour ago
- Newsweek
Map Shows States Where COVID Is Rising
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. COVID-19 cases are reported to be rising in 27 states and "likely growing" in 12 states more as well as in Washington D.C., according to the latest data from the U.S. Centers for Disease Control and Prevention (CDC). The national health body warned that COVID-19 infections are estimated to be "growing or likely growing in 40 states [including D.C.], declining or likely declining in zero states, and not changing in nine states," as of July 29. "COVID-19 activity is increasing in many Mid-Atlantic, Southeast, Southern, and West Coast states," the CDC said on August 1. The percentage of positive cases is increasing nationally and while emergency department visits for COVID-19 are low, these visits are rising among all ages. "The current rise in COVID-19 cases is likely multifactorial," Dr. Steven Goldberg, primary care/urgent care physician and chief medical officer at HealthTrackRx—a PCR testing company that works with the CDC to help create fast testing for viruses including COVID-19— told Newsweek. He explained: "Increased summer travel, indoor gatherings due to high temperatures, waning vaccine immunity and the emergence of immune-evasive Omicron subvariants like KP.3 and LB.1 all play a role." "Wastewater surveillance, along with anecdotal reports of increased COVID-19–related ER and urgent care visits, corroborate this increase," Goldberg said. "Notably, real-time transmission estimates (Rt) show values above 1 in most states, indicating active spread." (Rt—the "effective reproduction number"—is an estimate of the average number of new infections caused by each infectious person.) The states with rising cases are each reported to have a more than 90 percent probability that the "COVID-19 epidemic is growing" there. The states with some of the highest probabilities include Florida (99.92 percent), Massachusetts (99.68 percent), Texas (99.52 percent) and Maryland (98.95 percent.) While the current summer wave of cases is less severe than previous peaks, "this surge may intensify further in the fall with back-to-school and return-to-office patterns unless mitigated by vaccine uptake and public awareness," Goldberg warned. The nine states where cases remain unchanged in recent days include Alaska, Hawaii, Idaho, Maine, Montana, Nevada, New Mexico, Rhode Island and Vermont. The percent of emergency department visits in these states was reported to be either low or very low, according to the CDC. According to Goldberg, several factors may explain the plateau in these nine states, including lower population density, such as in Montana and Alaska, as well limited large-scale indoor gatherings, and higher vaccine booster uptake. "It's also possible that regional Rt estimates are slightly lagging and may rise in future updates," he noted. The physician says updated vaccines targeting the latest Omicron sublineages, which are expected to emerge in the fall this year, are "essential" for combating rising cases and new variants. He said: "These next-generation vaccines are designed to enhance protection against immune-evasive strains like the Omicron-subvariants KP.3 and LB.1." Goldberg says that while reinstating broad health mandates may not be necessary at this stage, "targeted recommendations are prudent," noting that supporting voluntary masking in healthcare settings, airports, and high-risk indoor gatherings can help reduce transmission. He advises encouraging vaccination, especially for people at high risk as well as those living with high-risk individuals. Newsweek has contacted the CDC for comment via email and its online media contact form. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about COVID-19? Let us know via health@
Business Wire
3 hours ago
- Business Wire
New Data Show Better Outcomes for Hospitalized Surgical Patients
WASHINGTON--(BUSINESS WIRE)--Patients in the hospital for surgeries had better outcomes in 2024 than they did in 2019, according to a new report released today by the American Hospital Association and Vizient®. The significant improvement aligned not only with better performance on patient safety metrics — such as reductions in infections and falls — but also with marked declines in three major surgical patient safety indicators: severe bleeding, sepsis and respiratory failure. The new findings build on a report AHA released in collaboration with Vizient last year showing that hospitals and health systems performed better on key patient safety and quality measures in the first quarter of 2024 than they did before the COVID-19 pandemic. In fact, hospitals' efforts to improve safety led to 200,000 Americans hospitalized between April 2023 and March 2024 surviving episodes of care they wouldn't have in 2019. 'The safety and quality improvements in surgical outcomes underscore the resilience and unwavering commitment of hospitals and health systems — and the millions of hospital team members across the country — to delivering better care to the patients and communities they serve,' said AHA President and CEO Rick Pollack. 'While hospitals are proud of these efforts, we know there is always more work to do to deliver the highest quality care possible.' 'These results of this analysis reflect the extraordinary efforts by hospitals to adapt and elevate surgical care,' said David Levine MD, Senior Vice President and Chief Medical Officer for Vizient. 'By leveraging advanced analytics and technology-driven insights, health systems are not only addressing the increasing complexity of inpatient surgical cases but are improving outcomes in meaningful, measurable ways.' KEY FINDINGS FROM TODAY'S REPORT In the first quarter of 2024, hospitalized surgical patients were nearly 20% more likely to survive than expected — based on the severity of their illnesses — compared to patients in the fourth quarter of 2019. This significant improvement aligned not only with better performance on patient safety metrics — such as reductions in infections and falls — but also with declines in three high-risk post-operative complications: hemorrhage (down 22.6%), sepsis (down 9.2%) and respiratory failure (down 18.9%). As an increasing number of surgical procedures shift to outpatient or ambulatory settings, the surgical patients who remain hospitalized tend to have greater clinical complexity and require higher acuity care. Vizient projects that this trend will continue to intensify over the next decade. The average length of stay for hospitalized surgical patients has increased by nearly one full day over the past five years. This rise correlates with increasing patient acuity and the concerning trend among commercial insurers to delay discharges and deny coverage for appropriate post-acute care services. About Vizient, Inc. Vizient, Inc., the nation's largest provider-driven healthcare performance improvement company, serves more than 65% of the nation's acute care providers, including 97% of the nation's academic medical centers, and more than 35% of the non-acute market. The Vizient contract portfolio represents $140 billion in annual purchasing volume enabling the delivery of cost-effective, high-value care. With its acquisition of Kaufman Hall in 2024, Vizient expanded its advisory services to help providers achieve financial, strategic, clinical and operational excellence. Headquartered in Irving, Texas, Vizient has offices throughout the United States. Learn more at About the American Hospital Association (AHA) The American Hospital Association (AHA) is a not-for-profit association of health care provider organizations and individuals that are committed to the health improvement of their communities. The AHA advocates on behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses and other caregivers – and the 43,000 health care leaders who belong to our professional membership groups. Founded in 1898, the AHA provides insight and education for health care leaders and is a source of information on health care issues and trends. For more information, visit the AHA website at
